preclinical research is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-12-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
=== Brazil === Stroganoff is a popular dish in Brazil, where it is known as estrogonofe or strogonoff. Estrogonofe is generally prepared with tomato paste or ketchup and mushrooms. Chicken is sometimes used instead of beef. Estrogonofe is generally eaten with cooked white rice and shoestring fries (batata palha).
=== 19th century === In 1878, Lilly hired his brother, James, as his first full-time salesman, and the subsequent sales team marketed the company's drugs nationally. By 1879, the company had grown to $48,000 in sales. The company moved its Indianapolis headquarters from Pearl Street to larger quarters at 36 South Meridian Street. In 1881, the company moved to its current headquarters in Indianapolis's south-side industrial area, and the company later purchased additional facilities for research and production. The same year, Lilly incorporated the business as Eli Lilly and Company, elected a board of directors, and issued stock to family members and close associates. Lilly's first innovative product was gelatin-coating for pills and capsules. The company's other early innovations included fruit flavorings and sugarcoated pills, which made the medicines easier to swallow. In 1882, Colonel Lilly's only son, Josiah K. Lilly Sr. (J. K.), a pharmaceutical chemist, graduated from the Philadelphia College of Pharmacy in Philadelphia, and returned to Indianapolis to join the family business as a superintendent of its laboratory. In 1883, the company contracted to mix and sell Succus Alteran, its first widely successful product and one its best sellers. The product was marketed as a "blood purifier" and as a treatment for syphilis, some types of rheumatism, and skin diseases such as eczema and psoriasis. By the late 1880s, Colonel Lilly was one of the Indianapolis area's leading businessmen, and the company had over 100 employees and $200,000 in annual sales.
=== Contestants === 1st - Manny Martinez, Bakery Owner from San Antonio, Texas 2/3/4th - Aaron Davis, Pastry Lead from Surprise, Arizona. 2/3/4th - Joel Gonzalez, Executive Pastry Chef from Scottsdale, Arizona 2/3/4th - Hollie Rivera, Assistant Pastry Chef from Winnipeg, Manitoba 5th - Lillian Chng, Home Bakery Owner from San Diego, California 6th - Thierry Aujard, Executive Pastry Chef from Norristown, Pennsylvania 7th - Megan Aucone, Pastry Chef and Cake Artist from Sayreville, New Jersey 8th - JL Hinojosa, Pastry Chef de Partie from Austin, Texas 9th - Carly Robertson, Bakery Owner from Lehi, Utah 10th - Samantha Santiago Torres, Executive Pastry Chef from Chicago, Illinois
Fox Islands (the main islands are Unimak, Akutan, Unalaska and Umnak) Islands of Four Mountains (the main islands are Yunaska and Chuginadak) Andreanof Islands (the main islands are Adak, Atka, Amlia, Seguam, Kanaga and Tanaga) Rat Islands (the main islands are Kiska and Amchitka) Near Islands (the main islands are Attu Island, Agattu Island and the Semichi Islands - Alaid, Nizki and Shemya) Commander Islands (the main islands are Bering and Medny) All six are located between 51° and 55° N latitude and 172° E and 163° W longitude. The largest islands in the Aleutians are Attu, and Unalaska, Umnak, and Unimak in the Fox Islands. The largest of those is Unimak Island, with an area of 1,571.41 mi2 (4,069.9 km2), followed by Unalaska Island, the only other Aleutian Island with an area over 1,000 square miles (2,600 km2). The axis of the archipelago near the mainland of Alaska has a southwest trend, but at Tanaga Island (about 178° W) its direction changes to the northwest. This change of direction corresponds to a curve in the line of volcanic fissures that have contributed their products to the building of the islands. Such curved chains are repeated about the Pacific Ocean in the Kuril Islands, the Japanese chain, and in the Philippines. All these island arcs are at the edge of the Pacific Plate and experience much seismic activity, but are still habitable; the Aleutians lie between the Pacific and North American tectonic plates. The general elevation is greatest in the eastern islands and least in the western.
== Structure == The Gβγ subunit is a dimer composed of two polypeptides, however it acts functionally as a monomer, as the individual subunits do not separate, and have not been found to function independently. The Gβ subunit is a member of the β-propeller family of proteins, which typically possess four to eight antiparallel β-sheets arranged in the shape of a propeller. Gβ contains a seven-bladed β-propeller, each blade arranged around a central axis and composed of four antiparallel β-sheets. The amino acid sequence contains seven WD repeat motifs of about 40 amino acids, each highly conserved and possessing the Trp-Asp dipeptide that gives the repeat its name. The Gγ subunit is considerably smaller than Gβ, and is unstable on its own, requiring interaction with Gβ to fold, explaining the close association of the dimer. In the Gβγ dimer, the Gγ subunit wraps around the outside of Gβ, interacting through hydrophobic associations, and exhibits no tertiary interactions with itself. The N terminus helical domains of the two subunits form a coiled coil with one another that typically extends away from the core of the dimer. To date, five β-subunit and eleven γ-subunit genes have been identified in mammals. The Gβ genes have very similar sequences, while significantly greater variation is seen in the Gγ genes, indicating that the functional specificity of the Gβγ dimer may be dependent on the type of Gγ subunit involved.
Sources: en.wikipedia.org
=== 1977–1981: Peak progressive era === After the conclusion of the 2112 tour, Rush recorded A Farewell to Kings (1977) and Hemispheres (1978) at Rockfield Studios in Monmouthshire, Wales. The albums had the band members expanding the progressive elements in their music. "As our tastes got more obscure", Lee said in an interview, "we discovered more progressive rock-based bands like Yes, Van der Graaf Generator, and King Crimson, and we were very inspired by those bands. They made us want to make our music more interesting and more complex, and we tried to blend that with our own personalities to see what we could come up with that was indisputably us." Increased synthesizer use, lengthy songs, and highly dynamic playing featuring complex time signature changes became a staple of Rush's compositions. To achieve a broader, more progressive sound, Lifeson began to experiment with classical and twelve-string guitars, and Lee added bass-pedal synthesizers and Minimoog. Likewise, Peart's percussion became diversified in the form of triangles, glockenspiel, wood blocks, cowbells, timpani, gong, and chimes. Beyond instrument additions, the band kept in stride with progressive rock trends by continuing to compose long, conceptual songs with science fiction and fantasy overtones. As the new decade approached, Rush gradually began to dispose of their older styles of music in favour of shorter and sometimes softer arrangements, due in part to the band's exhaustion from recording Hemispheres.
=== Disorders involving the immune mechanism === 279 Disorders involving the immune mechanism 279.0 Deficiency of humoral immunity 279.00 Hypogammaglobulinemia unspecified 279.01 Selective IgA immunodeficiency 279.02 Selective IgM immunodeficiency 279.03 Other selective immunoglobulin deficiencies 279.04 Congenital hypogammaglobulinemia 279.05 Immunodeficiency with increased IgM 279.06 Common variable immunodeficiency 279.09 Other deficiency of humoral immunity 279.1 Deficiency of cell-mediated immunity 279.10 Immunodeficiency with predominant t-cell defect unspecified 279.11 DiGeorge syndrome 279.12 Wiskott–Aldrich syndrome 279.13 Nezelof syndrome 279.19 Other deficiency of cell-mediated immunity 279.2 Combined immunity deficiency Severe combined immunodeficiency 279.3 Unspecified immunity deficiency 279.4 Autoimmune disease not elsewhere classified 279.5 Graft-versus-host disease 279.8 Other specified disorders involving the immune mechanism 279.9 Unspecified disorder of immune mechanism
Colombia is a member of global and regional organizations including the UN, the WTO, the OECD, the OAS, the CIVETS, the Pacific Alliance and the Andean Community; it is a NATO Global Partner and a major non-NATO ally of the United States.
Eicosanoids, retinoids, oestrogens, melanocyte-stimulating hormone, endothelins, psoralens, hydantoin, forskolin, cholera toxin, isobutylmethylxanthine, diacylglycerol analogues, and UV irradiation all trigger melanogenesis and, in turn, pigmentation.
Sources: en.wikipedia.org
Among the most important governance standards are rights vote for who is on the board of directors for investors of labour and capital. A Draft Fifth Company Law Directive proposed in 1972, which would have required EU-wide rights for employees to vote for boards stalled mainly because it attempted to require two-tier board structures, although most EU member states have codetermination today with unified boards. The Shareholder Rights Directive 2007 requires shareholders be able to make proposals, ask questions at meetings, vote by proxy and vote through intermediaries. This has become increasingly important as most company shares are held by institutional investors (primarily asset managers or banks, depending on the member state) who are holding "other people's money". A large proportion of this money comes from employees and other people saving for retirement, but who do not have an effective voice. Unlike Switzerland after a 2013 people's initiative, or the U.S. Dodd-Frank Act 2010 in relation to brokers, the EU has not yet prevented intermediaries casting votes without express instructions of beneficiaries. This concentrates power into a small number of financial institutions, and creates the potential for conflicts of interest where financial institutions sell retirement, banking or products to companies in which they cast votes with other people's money. A series of rights for ultimate investors exist in the Institutions for Occupational Retirement Provision Directive 2003.
Lula's administration has also sought to restore Brazil's international role and expand its participation in multilateral diplomacy, while placing greater emphasis on environmental policy and efforts to combat deforestation. Brazil hosted the 2025 United Nations Climate Change Conference (COP30) in Belém. The government's foreign policy was also affected by international tensions and economic disputes, including the Brazil–United States diplomatic crisis of 2025–2026. The administration has been marked by political controversies and debates over the regulation of digital platforms, disinformation, freedom of expression, and the protection of children online. Domestically, the government has faced challenges in its relationship with Congress and debates over public spending and economic policy. Initially composed of 37 ministries, the administration underwent changes to its ministerial structure and adopted a new government identity and slogan, "On the Side of the Brazilian People", in 2025.
== External links == "Opioid Receptors: NOP". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2016-03-03. Retrieved 2008-12-09. nociceptin+receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: P41146 (Nociceptin receptor) at the PDBe-KB. This article incorporates text from the United States National Library of Medicine, which is in the public domain.
=== Dairy products === Chinese in earlier dynasties evidently drank milk and ate dairy products, although not necessarily from cows, but kumis (fermented mare's milk) or goat's milk. Kumis was historically consumed in northern China. China also has a number of native cheeses, mostly of the non-Han culinary traditions. Nguri, however, is a traditional cheese of southern China — mainly Fujian, Guangdong, and the area around Shanghai — historically consumed by the Han. It is a buffalo-milk cheese traditionally served in small amounts on congee. China's non-Han cheeses include Uyghur kurut, Mongolian byaslag and eezgii, Tibetian chhurpi, and Yi rushan and rubing.
=== Fifth Republic === December 23, 1958: Decree amending various criminal provisions to introduce a fifth class of police contraventions; notably punishes passive soliciting. December 30, 1958: The term "birth allowance" replaces "maternity allowance," and the conditions for both that and the single wage allowance are modified. February 4, 1959: Ordinance on the general status of civil servants, which includes the principle of non-discrimination based on sex, except in certain exceptional cases, notably in the national police. April 9, 1960: Decree concerning the family record book. November 25, 1960: Ordinance on the fight against pimping. November 25, 1960: By decree, passive soliciting becomes a 3rd-class offense, active soliciting a 5th-class offense. December 2, 1960: France ratifies the United Nations Convention for the Suppression of the Traffic in Persons and of the Exploitation of the Prostitution of Others; the sanitary and social registry of prostitutes — created by law on April 24, 1946, and listing about 30,000 people in 1960 — is abolished. July 13, 1965: Law reforming matrimonial regimes: modification of the legal regime for marriages without a contract: the wife is free to manage her own property and pursue professional activity, no longer needing her husband's consent. September 29, 1965: Order establishing a study and liaison committee on women's labor issues. July 11, 1966: Law reforming adoption. December 30, 1966: Law on job protection in cases of maternity.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Dihexa is a synthetic peptide analog related to angiotensin IV. It is studied in preclinical research for effects on neural signaling and synapse formation. It is not an approved medicine.